February 11, 2015
Spellman DS et al. Prot Clin Appl 2015;9:715-731.
Development and Evaluation of a Multiplexed Mass Spectrometry-Based Assay for Measuring Candidate Peptide Biomarkers in Alzheimer’s Disease Neuroimaging Initiative (ADNI) CSF
You might also be interested by
Posters
Can Microsampling Devices Coupled with Intact Mass High-Resolution Mass Spectrometry Improve M-Protein Monitoring and Simplify Minimal Residual Disease Assessment in Multiple Myeloma?
November 10, 2025
Proteomics/Mass Spectrometry
More infoWeb News
CellCarta Expands Proteomics Offering with Olink® Reveal Assay
August 6, 2025
Proteomics/Mass Spectrometry
More infoBrochures & Infographics
Supporting Your Targeted Protein Degradation Strategies
April 1, 2025
Proteomics/Mass Spectrometry
More infoWeb News
CellCarta Joins Olink™ Certified Service Provider Network in China
February 13, 2025
Proteomics/Mass Spectrometry
More info